Cargando…
Economic evaluation in genomic medicine /
Economic Evaluation in Genomic Medicine introduces health economics and economic evaluation to genomic clinicians and researchers, while also introducing the topic to health economists. Each chapter includes an executive summary, questions, and case studies, along with supplementary online materials...
| Clasificación: | Libro Electrónico |
|---|---|
| Autores principales: | , , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London :
Academic Press, an imprint of Elsevier,
[2015]
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn905543970 | ||
| 003 | OCoLC | ||
| 005 | 20231120111947.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 150324s2015 enk ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d N$T |d IDEBK |d OPELS |d E7B |d YDXCP |d EBLCP |d FEM |d LIP |d OCLCO |d MERER |d OCLCO |d OCLCQ |d CASUM |d OCLCO |d OCLCQ |d MERUC |d OCLCF |d OCLCO |d U3W |d OCLCO |d D6H |d OCLCQ |d WYU |d OCLCA |d CUY |d LOA |d ICG |d K6U |d COCUF |d OCLCQ |d VT2 |d DKC |d AU@ |d OCLCO |d OCLCQ |d ZCU |d OCLCO |d OCLCQ |d UKMGB |d OCLCA |d S2H |d OCLCO |d OCL |d OCLCQ |d OCLCO | ||
| 015 | |a GBB549190 |2 bnb | ||
| 016 | 7 | |a 101659770 |2 DNLM | |
| 016 | 7 | |a 017158005 |2 Uk | |
| 019 | |a 905997071 |a 932054667 |a 968055909 |a 969047173 |a 1066432110 |a 1088992322 |a 1228597293 | ||
| 020 | |a 9780128016114 |q (electronic bk.) | ||
| 020 | |a 0128016116 |q (electronic bk.) | ||
| 020 | |a 0128014970 | ||
| 020 | |a 9780128014974 | ||
| 020 | |z 9780128014974 | ||
| 035 | |a (OCoLC)905543970 |z (OCoLC)905997071 |z (OCoLC)932054667 |z (OCoLC)968055909 |z (OCoLC)969047173 |z (OCoLC)1066432110 |z (OCoLC)1088992322 |z (OCoLC)1228597293 | ||
| 043 | |a n-cn--- | ||
| 050 | 4 | |a RB155.6 | |
| 060 | 4 | |a 2015 E-898 | |
| 060 | 4 | |a QU 460 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.042 |2 23 |
| 100 | 1 | |a Fragoulakis, Vasilios, |e author. | |
| 245 | 1 | 0 | |a Economic evaluation in genomic medicine / |c Vasilios Fragoulakis, Christina Mitropoulou, Marc S. Williams, George P. Patrinos. |
| 264 | 1 | |a London : |b Academic Press, an imprint of Elsevier, |c [2015] | |
| 264 | 4 | |c �2015 | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file | ||
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Vendor-supplied metadata. | |
| 505 | 0 | |a Front Cover; Economic Evaluation in Genomic Medicine; Copyright Page; Contents; Preface; 1 Economic Evaluation in Health Care: Evidence-Based Medicine and Evidence-Based Health Economics; The Scope of Economic Evaluation of Health Services: The Science of Economics; Evidence-Based Medicine and Evidence-Based Health Economics; The Necessity of Drafting Economic Evaluations; References; 2 Genomic Medicine Today: An Introduction for Health Economists; Introduction; Pharmacogenomics and Genomic Medicine; Applications of Pharmacogenomics; Oncology Examples; Cardiology Examples. | |
| 505 | 8 | |a Psychiatric ExamplesInfectious Disease Examples; Facing the Current Challenges of Genomic Medicine; Education of Health Professionals; Demonstration of Clinical Utility; Health Care Costs; Insurance and Privacy Issues; Conclusions and Future Perspectives; References; 3 Economic Evaluation and Genomic Medicine: What Can They Learn from Each Other?; Introduction; Genomics in Health Economics; Triangulating Genomics with Health Technology Assessment and Health Economics; Economic Evaluation in the Postgenomic Era; References; 4 Introduction to the Technical Issues of Economic Evaluation. | |
| 505 | 8 | |a Sensitivity AnalysisThe Value of Information and Bayesian Analysis; Conclusions; References; 6 Economic Evaluation in the Genomic Era: Some Examples from the Field; Introduction; Using Pharmacogenomics to Prevent Adverse Events; Balancing Adverse Events and Efficacy; The Disease Makes a Difference; Perspectives on Perspective; Defining Performance Characteristics; Cost-Effectiveness Analysis in Genomic Medicine and the Developing World; Conclusions; References; 7 Special Requirements for Economic Evaluation and Health Technology Assessment in Genomic Medicine; Introduction; Analysis Costs. | |
| 520 | |a Economic Evaluation in Genomic Medicine introduces health economics and economic evaluation to genomic clinicians and researchers, while also introducing the topic to health economists. Each chapter includes an executive summary, questions, and case studies, along with supplementary online materials, including process guides, maps, flow charts, diagrams, and economic evaluation spreadsheets to enhance the learning process. The text can easily be used as course material for related graduate and undergraduate courses, providing a succinct overview of the existing, state-of-the-art application of economic evaluation to genomic healthcare and precision medicine. Interrelates economic evaluation and genomic medicine Instructs healthcare professionals and bioscientists about economic evaluation in genomic medicine Teaches health economists about application of economic evaluation in genomic medicine Introduces health economics and economic evaluation to clinicians and researchers involved in genomics Includes process guides, maps, flow charts and diagrams. | ||
| 650 | 0 | |a Medical genetics. | |
| 650 | 0 | |a Medical genetics |x Research |x Economic aspects. | |
| 650 | 0 | |a Genomics |x Economic aspects |z Canada. | |
| 650 | 0 | |a Cost effectiveness. | |
| 650 | 1 | 2 | |a Genomics |x economics |0 (DNLM)D023281Q000191 |
| 650 | 2 | |a Genetics, Medical |0 (DNLM)D005826 | |
| 650 | 2 | 2 | |a Cost-Benefit Analysis |0 (DNLM)D003362 |
| 650 | 6 | |a G�en�etique m�edicale. |0 (CaQQLa)201-0001432 | |
| 650 | 6 | |a G�en�etique m�edicale |0 (CaQQLa)201-0001432 |x Recherche |0 (CaQQLa)201-0379425 |x Aspect �economique. |0 (CaQQLa)201-0374333 | |
| 650 | 6 | |a G�enomique |0 (CaQQLa)201-0363181 |x Aspect �economique |0 (CaQQLa)201-0374333 |z Canada. |0 (CaQQLa)201-0407174 | |
| 650 | 6 | |a Co�ut-efficacit�e. |0 (CaQQLa)201-0069422 | |
| 650 | 7 | |a cost benefit analysis. |2 aat |0 (CStmoGRI)aat300054596 | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Cost effectiveness |2 fast |0 (OCoLC)fst00880707 | |
| 650 | 7 | |a Medical genetics |2 fast |0 (OCoLC)fst01014133 | |
| 651 | 7 | |a Canada |2 fast |0 (OCoLC)fst01204310 | |
| 655 | 4 | |a Internet Resources. | |
| 700 | 1 | |a Mitropoulou, Christina, |e author. | |
| 700 | 1 | |a Williams, Marc S., |e author. | |
| 700 | 1 | |a Patrinos, George P., |e author. | |
| 776 | 0 | 8 | |i Print version: |a Fragoulakis, Vasilios. |t Economic Evaluation in Genomic Medicine. |d Burlington : Elsevier Science, �2015 |z 9780128014974 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780128014974 |z Texto completo |